Jung Ki Jo1, Seong Jin Jeong1, Sung Kyu Hong1, Seok-Soo Byun1, Sang Eun Lee1, Jong Jin Oh2. 1. Department of Urology, Seoul National University Bundang Hospital, 82, Gumi-ro, 173 Beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, 463-707, Korea. 2. Department of Urology, Seoul National University Bundang Hospital, 82, Gumi-ro, 173 Beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, 463-707, Korea. bebsuzzang@naver.com.
Abstract
PURPOSE: To investigate the impact of preoperative anemia (PA) on oncologic outcomes among patients who underwent radical cystectomy (RC) for bladder cancer. METHODS: We reviewed the records of 200 patients undergoing RC between October 2003 and December 2014. Patients were categorized according to PA status. We performed multivariable Cox regression analyses to assess the impact of PA on oncological outcomes. RESULTS: Among 200 patients, 81 patients (40.5%) had PA according to definition of the WHO classification. Fifty-two (26%) of 200, 12 (6%) of 200 and 61 (30.5%) of 200 patients experienced the disease recurrence (DR), cancer-specific mortality (CSM) and all-cause mortality (ACM), respectively. In Kaplan-Meier analysis, the non-PA group showed a significantly higher 5-year DR-free survival than PA group (log-rank test: p = 0.018). The non-PA group showed a similar pattern of CSM and ACM (p = 0.004 and p = 0.037, respectively). In multivariable Cox proportional hazards analysis, PA was significantly associated with DR (HR 1.86, 95% CI, p = 0.04) and ACM (HR 2.13, 95% CI, p = 0.006) after adjusting other factors. CONCLUSIONS: The preoperative anemic bladder cancer patients who underwent RC had worse oncological outcomes than non-anemic bladder cancer patients.
PURPOSE: To investigate the impact of preoperative anemia (PA) on oncologic outcomes among patients who underwent radical cystectomy (RC) for bladder cancer. METHODS: We reviewed the records of 200 patients undergoing RC between October 2003 and December 2014. Patients were categorized according to PA status. We performed multivariable Cox regression analyses to assess the impact of PA on oncological outcomes. RESULTS: Among 200 patients, 81 patients (40.5%) had PA according to definition of the WHO classification. Fifty-two (26%) of 200, 12 (6%) of 200 and 61 (30.5%) of 200 patients experienced the disease recurrence (DR), cancer-specific mortality (CSM) and all-cause mortality (ACM), respectively. In Kaplan-Meier analysis, the non-PA group showed a significantly higher 5-year DR-free survival than PA group (log-rank test: p = 0.018). The non-PA group showed a similar pattern of CSM and ACM (p = 0.004 and p = 0.037, respectively). In multivariable Cox proportional hazards analysis, PA was significantly associated with DR (HR 1.86, 95% CI, p = 0.04) and ACM (HR 2.13, 95% CI, p = 0.006) after adjusting other factors. CONCLUSIONS: The preoperative anemic bladder cancerpatients who underwent RC had worse oncological outcomes than non-anemic bladder cancerpatients.
Authors: M Gierth; R Mayr; A Aziz; S Krieger; B Wullich; A Pycha; M Lodde; U Salvadori; J Bründl; H M Fritsche; F Hofstädter; M T Pawlik; W Otto; M May; M Burger; S Denzinger Journal: J Cancer Res Clin Oncol Date: 2015-04-02 Impact factor: 4.553
Authors: Matthias May; Patrick J Bastian; Sabine Brookman-May; Hans-Martin Fritsche; Derya Tilki; Wolfgang Otto; Christian Bolenz; Christian Gilfrich; Lutz Trojan; Edwin Herrmann; Rudolf Moritz; Arne Tiemann; Stefan C Müller; Jörg Ellinger; Alexander Buchner; Christian G Stief; Wolf F Wieland; Thomas Höfner; Markus Hohenfellner; Axel Haferkamp; Jan Roigas; Mario Zacharias; Philipp Nuhn; Maximilian Burger Journal: Urol Oncol Date: 2011-11-06 Impact factor: 3.498
Authors: Giacomo Novara; Robert S Svatek; Pierre I Karakiewicz; Eila Skinner; Vincenzo Ficarra; Yves Fradet; Yair Lotan; Hendrik Isbarn; Umberto Capitanio; Patrick J Bastian; Wassim Kassouf; Hans-Martin Fritsche; Jonathan I Izawa; Derya Tilki; Colin P Dinney; Seth P Lerner; Mark Schoenberg; Bjoern G Volkmer; Arthur I Sagalowsky; Shahrokh F Shariat Journal: J Urol Date: 2010-06 Impact factor: 7.450
Authors: Gunnar Birgegård; Matti S Aapro; Carsten Bokemeyer; Mario Dicato; Peter Drings; Javier Hornedo; Maciej Krzakowski; Heinz Ludwig; Sergio Pecorelli; Hans Schmoll; Maurice Schneider; Dirk Schrijvers; Daniel Shasha; Simon Van Belle Journal: Oncology Date: 2005 Impact factor: 2.935
Authors: Leif Saager; Alparslan Turan; Luke F Reynolds; Jarrod E Dalton; Edward J Mascha; Andrea Kurz Journal: Anesth Analg Date: 2013-03-14 Impact factor: 5.108
Authors: Wen-Chih Wu; Tracy L Schifftner; William G Henderson; Charles B Eaton; Roy M Poses; Georgette Uttley; Satish C Sharma; Michael Vezeridis; Shukri F Khuri; Peter D Friedmann Journal: JAMA Date: 2007-06-13 Impact factor: 56.272